Evidence map›Paper›PMID 15783259›Full record

ArticlePLoS medicine2005

Is it always unethical to use a placebo in a clinical trial?

Andreas Stang, Hans-Werner Hense, Karl-Heinz Jöckel, Erick H Turner, Martin R Tramèr

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Effectiveness ofNarra J · 2023
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Ethical considerations in research involving children.Current allergy and asthma reports · 2005
    Review
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Andreas StangInstitute of Medical Epidemiology, Biometry, and Informatics at the Medical Faculty of the Martin-Luther-University of Halle-Wittenberg, Germany. andreas.stang@medizin.uni-halle.de
Hans-Werner Hense
Karl-Heinz Jöckel
Erick H Turner
Martin R Tramèr
Martin Luther University Halle-Wittenberg · DEUniversity of Duisburg-Essen · DEUniversity of Geneva · CHUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background to the debatePlacebos are used in trials to conceal whether a treatment is being given or not and hence to control for the psychosomatic effects of offering treatment. Placebo-controlled trials are controversial. Critics of such trials argue that if a proven effective therapy exists, a placebo should not be used. But proponents argue that placebo trials are still crucial to prove the efficacy and safety of many treatments.

Indexed as

PlacebosEthics, MedicalHumansRandomized Controlled Trials as TopicPlacebos

Identifiers

PMID15783259
PMCPMC1069666
OpenAlexW2163913679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.